Shinji Nakamichi

3PUBLICATIONS
26CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jun 28, 2024
Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression.

Naomi Onda, Shinji Nakamichi, Mariko Hirao

|Jan 02, 2024
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study).

Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi

|Jun 14, 2022
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report.

Anna Hayashi, Shinji Nakamichi, Yukako Nakayama

Pageof 1

Frequent Collaborators

2 joint publications

Akihiko Miyanaga

2 joint publications

Rintaro Noro

1 joint publications

Natsuki Takano

1 joint publications

Takehiro Tozuka